miocamycin has been researched along with Infections, Pseudomonas in 2 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 2 (100.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 0 (0.00) | 29.6817 |
2010's | 0 (0.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Homma, JY; Kasai, T | 1 |
Homma, JY; Iki, Y; Inatomi, K; Kasai, T; Kunii, O; Mashimo, K; Nishimura, Y; Shimada, K; Takigami, T; Tanimoto, H | 1 |
2 other study(ies) available for miocamycin and Infections, Pseudomonas
Article | Year |
---|---|
Synergistic effects of a macrolide and a cell wall-affecting antibiotic on Pseudomonas aeruginosa in vitro and in vivo. 1. Combined effects of a macrolide and a peptide antibiotic.
Topics: Animals; Anti-Bacterial Agents; Cell Wall; Drug Synergism; Leucomycins; Mice; Microbial Sensitivity Tests; Miocamycin; Polymyxin B; Polymyxins; Pseudomonas aeruginosa; Pseudomonas Infections; Time Factors | 1982 |
Combination therapy using 9,3"-di-O-acetyl-midecamycin with beta-lactam antibiotics against Pseudomonas aeruginosa infection.
Topics: Adult; Agammaglobulinemia; Aged; Anti-Bacterial Agents; beta-Lactams; Bronchiectasis; Bronchitis; Drug Therapy, Combination; Female; Humans; Leucomycins; Male; Middle Aged; Miocamycin; Pseudomonas aeruginosa; Pseudomonas Infections; Pulmonary Emphysema; Urinary Bladder, Neurogenic | 1981 |